Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

Chin SF, Wang Y, Thorne NP, Teschendorff AE, Pinder SE, Vias M, Naderi A, Roberts I, Barbosa-Morais NL, Garcia MJ, Iyer NG, Kranjac T, Robertson JF, Aparicio S, Tavaré S, Ellis I, Brenton JD, Caldas C.

Oncogene. 2007 Mar 22;26(13):1959-70. Epub 2006 Sep 25.

PMID:
17001317
2.

Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.

Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL.

Cancer Res. 2004 Dec 1;64(23):8541-9.

3.

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C, Richon C, Yan K, Wang B, Vassal G, Delaloge S, Hortobagyi GN, Symmans WF, Lazar V, Pusztai L.

Clin Cancer Res. 2009 Jan 15;15(2):441-51. doi: 10.1158/1078-0432.CCR-08-1791.

4.

Bladder cancer stage and outcome by array-based comparative genomic hybridization.

Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):7012-22.

5.

Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, Waldman FM.

Am J Pathol. 1995 Oct;147(4):905-11.

6.

Integrated profiling of basal and luminal breast cancers.

Adélaïde J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F, Charafe-Jauffret E, Cervera N, Desplans J, Parzy D, Schoenmakers E, Viens P, Jacquemier J, Birnbaum D, Bertucci F, Chaffanet M.

Cancer Res. 2007 Dec 15;67(24):11565-75.

7.

Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.

Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J.

Cancer Res. 2003 Dec 15;63(24):8861-8.

8.

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.

Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR.

Genes Chromosomes Cancer. 2006 Nov;45(11):1033-40.

PMID:
16897746
9.

Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.

Snijders AM, Nowee ME, Fridlyand J, Piek JM, Dorsman JC, Jain AN, Pinkel D, van Diest PJ, Verheijen RH, Albertson DG.

Oncogene. 2003 Jul 3;22(27):4281-6.

PMID:
12833150
10.

Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.

Melchor L, Honrado E, Huang J, Alvarez S, Naylor TL, García MJ, Osorio A, Blesa D, Stratton MR, Weber BL, Cigudosa JC, Rahman N, Nathanson KL, Benítez J.

Clin Cancer Res. 2007 Dec 15;13(24):7305-13.

11.

Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.

Mosse YP, Diskin SJ, Wasserman N, Rinaldi K, Attiyeh EF, Cole K, Jagannathan J, Bhambhani K, Winter C, Maris JM.

Genes Chromosomes Cancer. 2007 Oct;46(10):936-49.

PMID:
17647283
12.

Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.

Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Ursule L, Nguyen C, Redon R, du Manoir S, Rodriguez C, Theillet C.

Cancer Res. 2004 Sep 15;64(18):6453-60.

13.

Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors.

Savola S, Klami A, Tripathi A, Niini T, Serra M, Picci P, Kaski S, Zambelli D, Scotlandi K, Knuutila S.

BMC Cancer. 2009 Jan 14;9:17. doi: 10.1186/1471-2407-9-17.

14.

Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation.

Arriola E, Lambros MB, Jones C, Dexter T, Mackay A, Tan DS, Tamber N, Fenwick K, Ashworth A, Dowsett M, Reis-Filho JS.

Lab Invest. 2007 Jan;87(1):75-83.

15.

High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP, Costa JL, Pinder SE, van de Wiel MA, Green AR, Ellis IO, Porter PL, Tavaré S, Brenton JD, Ylstra B, Caldas C.

Genome Biol. 2007;8(10):R215.

16.

Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas.

Vékony H, Röser K, Löning T, Ylstra B, Meijer GA, van Wieringen WN, van de Wiel MA, Carvalho B, Kok K, Leemans CR, van der Waal I, Bloemena E.

Genes Chromosomes Cancer. 2009 Feb;48(2):202-12. doi: 10.1002/gcc.20631.

PMID:
19009612
17.

High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.

Jönsson G, Staaf J, Olsson E, Heidenblad M, Vallon-Christersson J, Osoegawa K, de Jong P, Oredsson S, Ringnér M, Höglund M, Borg A.

Genes Chromosomes Cancer. 2007 Jun;46(6):543-58.

PMID:
17334996
18.

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.

Simpson PT, Reis-Filho JS, Lambros MB, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Dexter T, Jones A, Reid L, Da Silva L, Shin SJ, Hardisson D, Ashworth A, Schmitt FC, Palacios J, Lakhani SR.

J Pathol. 2008 Jul;215(3):231-44. doi: 10.1002/path.2358.

PMID:
18473330
19.

Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array.

Jung SH, Shin SH, Yim SH, Choi HS, Lee SH, Chung YJ.

Exp Mol Med. 2009 Jul 31;41(7):462-70. doi: 10.3858/emm.2009.41.7.051.

20.

Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.

Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Rougé C, Ursule L, Nguyen C, Bibeau F, Rodriguez C, Theillet C.

Br J Cancer. 2006 Nov 20;95(10):1439-47. Epub 2006 Oct 24.

Supplemental Content

Support Center